Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA245000
Max Phase: Preclinical
Molecular Formula: C45H64N8O10
Molecular Weight: 877.05
Molecule Type: Protein
Associated Items:
ID: ALA245000
Max Phase: Preclinical
Molecular Formula: C45H64N8O10
Molecular Weight: 877.05
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(C)C[C@@H](NC(=O)[C@H](NC(=O)[C@H](NC(=O)[C@@H](Cc1ccc(O)cc1)NC(=O)[C@H]1CCCN1C(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](N)[C@@H](C)O)C(C)C)C(C)C)C(=O)O
Standard InChI: InChI=1S/C45H64N8O10/c1-23(2)19-34(45(62)63)50-42(59)37(24(3)4)52-43(60)38(25(5)6)51-39(56)32(20-27-14-16-29(55)17-15-27)48-40(57)35-13-10-18-53(35)44(61)33(49-41(58)36(46)26(7)54)21-28-22-47-31-12-9-8-11-30(28)31/h8-9,11-12,14-17,22-26,32-38,47,54-55H,10,13,18-21,46H2,1-7H3,(H,48,57)(H,49,58)(H,50,59)(H,51,56)(H,52,60)(H,62,63)/t26-,32-,33-,34-,35-,36-,37-,38-/m1/s1
Standard InChI Key: VDSZPHRCVCKNGA-IWMGITFUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 877.05 | Molecular Weight (Monoisotopic): 876.4745 | AlogP: 1.22 | #Rotatable Bonds: 21 |
Polar Surface Area: 285.38 | Molecular Species: ACID | HBA: 10 | HBD: 10 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.93 | CX Basic pKa: 7.62 | CX LogP: -0.28 | CX LogD: -0.47 |
Aromatic Rings: 3 | Heavy Atoms: 63 | QED Weighted: 0.07 | Np Likeness Score: 0.03 |
1. Jung KY, Moon HD, Lee GE, Lim HH, Park CS, Kim YC.. (2007) Structure-activity relationship studies of spinorphin as a potent and selective human P2X(3) receptor antagonist., 50 (18): [PMID:17676725] [10.1021/jm070114m] |
Source(1):